Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (361-370 of 2,090) with videos related to

Pageof 209
Sort By:
RMD Open|July 5, 2025
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatismsMaxime Beretta, Emmanuel Martin, Olivier Fogel, et al.
RMD Open|July 25, 2025
Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumaticaYoshiya Tanaka, Toshiya Takahashi, Toshiki Fukasawa, et al.
RMD Open|June 25, 2025
Computed tomography-derived quantitative imaging biomarkers enable the prediction of disease manifestations and survival in patients with systemic sclerosisMalte Maria Sieren, Hanna Grasshoff, Gabriela Riemekasten, et al.
RMD Open|June 25, 2025
Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental studyIlse van Es, Johanna E Vriezekolk, Nathan den Broeder, et al.
RMD Open|December 21, 2025
Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancerAstrid Dauchez, Charles Dariane, Jacques Fechtenbaum, et al.
RMD Open|December 11, 2025
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo studyVanessa Smith, Stefano Soldano, Rosanna Campitiello, et al.
RMD Open|November 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relativesRomain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, et al.
RMD Open|June 22, 2025
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patientsDamiano Currado, Francesca Trunfio, Francesca Saracino, et al.
RMD Open|June 19, 2025
Bone health in juvenile idiopathic arthritis compared with controls based on a Norwegian observational studyAnette Lundestad, Lena Cetrelli, Oskar Welander Angenete, et al.
RMD Open|December 24, 2024
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseasesMartin Aringer, Oliver Distler, Anna-Maria Hoffmann-Vold, et al.
Pageof 209

Showing results (361-370 of 2,090) with videos related to

Sort By:
Pageof 209
RMD Open|July 5, 2025
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatismsMaxime Beretta, Emmanuel Martin, Olivier Fogel, et al.
RMD Open|July 25, 2025
Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumaticaYoshiya Tanaka, Toshiya Takahashi, Toshiki Fukasawa, et al.
RMD Open|June 25, 2025
Computed tomography-derived quantitative imaging biomarkers enable the prediction of disease manifestations and survival in patients with systemic sclerosisMalte Maria Sieren, Hanna Grasshoff, Gabriela Riemekasten, et al.
RMD Open|June 25, 2025
Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental studyIlse van Es, Johanna E Vriezekolk, Nathan den Broeder, et al.
RMD Open|December 21, 2025
Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancerAstrid Dauchez, Charles Dariane, Jacques Fechtenbaum, et al.
RMD Open|December 11, 2025
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo studyVanessa Smith, Stefano Soldano, Rosanna Campitiello, et al.
RMD Open|November 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relativesRomain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, et al.
RMD Open|June 22, 2025
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patientsDamiano Currado, Francesca Trunfio, Francesca Saracino, et al.
RMD Open|June 19, 2025
Bone health in juvenile idiopathic arthritis compared with controls based on a Norwegian observational studyAnette Lundestad, Lena Cetrelli, Oskar Welander Angenete, et al.
RMD Open|December 24, 2024
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseasesMartin Aringer, Oliver Distler, Anna-Maria Hoffmann-Vold, et al.
Pageof 209